Frank Harder
Keine laufenden Positionen mehr
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Knud Carsten Lønfeldt | M | 77 | 6 Jahre | |
| Marianne Weile Nonboe | F | 64 | 4 Jahre | |
| Thea Wulff Olesen | F | 58 | 8 Jahre | |
| Niels Tækker Foged | M | 63 | 6 Jahre | |
| Peter Morch Eriksen | M | 64 | 9 Jahre | |
| Carl Eistrup | M | - |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | - |
| Peter Nordkild | M | 69 | 6 Jahre | |
| Pia E. Ringholm | F | - |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | - |
| Fredric D. Price | M | 78 |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | 1 Jahre |
| Finn Fjorder | M | - | 4 Jahre | |
| Laura von Kobyletzki | M | 53 | 1 Jahre | |
| Gry Louise Husby Larsen | F | - | 8 Jahre | |
| Roar Bjørk Seeger | M | 60 | - | |
| Torben Arnth Nielsen | M | 64 | 8 Jahre | |
| Mikkel Dührkop | M | - |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | - |
| Claus Crone Fuglsang | M | 56 | 1 Jahre | |
| Thomas Magnussen | M | 71 | 8 Jahre | |
| Jan Honoré | M | - |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | - |
| Otto Rasmussen | M | - | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Dänemark | 19 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Frank Harder
- Persönliches Netzwerk
